The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an e...

por Dayyani, Farshid, Zurita, Amado J., Nogueras-González, Graciela M., Slack, Rebecca, Millikan, Randall E., Araujo, John C., Gallick, Gary E., Logothetis, Christopher J., Corn, Paul G.
Publicado 2016

Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study

por Pasqualini, Renata, Millikan, Randall E, Christianson, Dawn R, Cardó-Vila, Marina, Driessen, Wouter H P, Giordano, Ricardo J, Hajitou, Amin, Hoang, Anh G, Wen, Sijin, Barnhart, Kirstin F, Baze, Wallace B, Marcott, Valerie D, Hawke, David H, Do, Kim-Anh, Navone, Nora M, Efstathiou, Eleni, Troncoso, Patricia, Lobb, Roy R, Logothetis, Christopher J, Arap, Wadih
Publicado 2015